Published 11 January 2022 Pouya Movahed Rad, researcher at Lund University and consultant psychiatrist. Photo: Tove Smeds Researchers at Lund University in Sweden have compared the effects of intravenous ketamine treatment with ECT treatment in severe depression. The results support the view that ketamine is a possible treatment, but also show that ECT treatment helps more people. In recent years,

https://www.medicine.lu.se/article/ect-more-effective-ketamine-severe-depression - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 11 January 2022 Dina Mansour Aly, one of the main authors behind the study, has carried out several genetical analyses. Photo: Petra Olsson Previous research from Lund University has shown that diabetes can be divided into five groups with different disease progression. A new study published in Nature Genetics demonstrates

https://www.medicine.lu.se/article/new-research-highlights-genetic-differences-between-different-forms-type-2-diabetes - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra) - published 11 January 2022 The study participants were served portions of white wheat bread during the two meals. After the meal intervention, blood sugar and insulin levels differed between different groups of participants. Photo: Petra Olsson A lot of research explains which diets may reduce the risk of developing type 2 diabetes. Much re

https://www.medicine.lu.se/article/bread-study-examines-role-genes-breaking-down-food - 2025-07-07

By agata [dot] garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 26 January 2022 Head of Department Tomas Deierborg. Photo: Kennet Ruona ...showing that competitors in the Vasaloppet cross-country ski race run a lower risk of suffering from anxiety than the general population. Your results have been reported by the New York Times, CNN and many other international news outlets. P

https://www.medicine.lu.se/article/hello-professor-tomas-deierborg-and-congratulations-considerable-international-attention-attracted - 2025-07-07

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 3 February 2022 Immune Thrombocytopenia, ITP, is an autoimmune bleeding disorder that is still treated with immunosuppressive drugs that cause serious side effects. Professor John Semple’s laboratory studies the pathophysiological mechanisms behind this disease and together with Dr. Drew Provan, London, UK, has recentl

https://www.medicine.lu.se/article/new-therapies-itp - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 8 September 2023 Swedish children have contributed to a new study that supports the theory that certain viruses are important for the development of type 1 diabetes. Photo: Johan Persson New research supports the theory that certain viral infections are of importance in the development of type 1 diabetes. An international

https://www.ludc.lu.se/article/new-study-virus-importance-development-type-1-diabetes - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 11 October 2023 Frances Ashcroft and Flemming Pociot from LUDC’s Scientific Advisory Board spent their time at the retreat listening to presentations and getting updates. Photo: Petra Olsson Lund University Diabetes Centre’s Scientific Advisory Board give researchers valuable feedback on ongoing research. Frances Ashcroft

https://www.ludc.lu.se/article/scientific-advisory-board-important-contributions-within-type-1-diabetes-research - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 5 October 2023 Using precision medicine in diabetes means that treatment of the disease and its complications can become more precise and accurate. Photo: iStock/Maya23K An international consensus report on diabetes identifies the potential for diabetes screening, better classification of type 2 diabetes, and biomarkers th

https://www.ludc.lu.se/article/new-report-highlights-opportunities-and-challenges-precision-diabetes-medicine - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 6 November 2023 Rashmi Prasad is awarded the Medeon stipend 2023 for her her research on heritability of type 2 diabetes. The stipend will be presented during the World Diabetes Day Skåne event. Photo: Petra Olsson How do heritability and the fetal environment affect the risk for the child to develop type 2 diabetes? This

https://www.ludc.lu.se/article/research-inherited-type-2-diabetes-awarded - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 15 November 2023 Magnus Cinthio, Isabel Goncalves and Tobias Erlöv win Lund University’s and Sparbanken Skåne’s award for Future Innovations to develop their idea further. Photo: Kennet Ruona Diabetes researcher and cardiologist Isabel Goncalves at Lund University Diabetes Centre (LUDC) has teamed up with ultrasound resear

https://www.ludc.lu.se/article/innovation-aims-identify-dangerous-atherosclerotic-plaques-wins-prize - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 December 2023 Tina Rönn, Charlotte Ling, and Karl Bacos have led the work on a study that examines whether epigenetic changes contribute to the development of type 2 diabetes. Photo: Petra Olsson Do epigenetic changes cause type 2 diabetes, or do the changes occur only after a person has become ill? A new study by resea

https://www.ludc.lu.se/article/epigenetic-changes-can-cause-type-2-diabetes - 2025-07-07

By press [at] med [dot] lu [dot] se (Faculty of Medicine at Lund University) - published 26 January 2024 Out of the 195 biomarkers examined, 13 were significantly associated with cardiovascular risk in people with type 2 diabetes. Photograph: iStock An international team of researchers has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease

https://www.ludc.lu.se/article/new-study-biomarkers-improve-prediction-cardiovascular-disease-type-2-diabetes - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 15 February 2024 Anna Blom and Ben C King have discovered that C3 protein protects insulin-producing cells. Photo: Rebecca Rosberg Much research on diabetes focuses on understanding what happens when the insulin-producing cells are destroyed. Researchers at Lund University have instead chosen to investigate what protects t

https://www.ludc.lu.se/article/protein-protects-insulin-producing-cells - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 28 February 2024 Coordinator Allan Vaag and Vice Coordinator Lena Eliasson lead the activities at EXODIAB and LUDC in close collaboration. Photograph: Petra Olsson Diabetes researchers Allan Vaag and Lena Eliasson are the new coordinators of Lund University Diabetes Centre (LUDC) and the strategic research area EXODIAB (Ex

https://www.ludc.lu.se/article/new-coordinators-strategic-research-area-diabetes - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 20 February 2024 Tune H Pers is the recipient of the Leif C. Groop Award for Outstanding Diabetes Research in 2024. Photograph: Peter Andrew Stanners Do you think that people with obesity have themselves to blame? Tune H Pers tries to dispel persistent myths through his research on the brain's role in the development of ob

https://www.ludc.lu.se/article/tune-h-pers-receives-award-outstanding-research-obesity-and-diabetes - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 18 April 2024 Vikas Yadav, Jan Nilsson, and Filiz Serifler at Lund University Diabetes Centre have contributed to the studies of the antibody that neutralises oxidised LDL particles. Photograph: Petra Olsson A treatment that has reduced plaque development in mice has now been tested in people with psoriasis. Jan Nilsson at

https://www.ludc.lu.se/article/new-treatment-atherosclerosis-may-reduce-risk-dying-heart-attack - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 21 May 2024 Sebastian Kalamajski edits fat cells with the editing technique CRISPR-Cas9. The aim with his project is to identify genetic variants and molecular pathways behind obesity that does not lead to type 2 diabetes. Photograph: Petra Olsson Why are some people with obesity protected from type 2 diabetes? Who is at r

https://www.ludc.lu.se/article/research-obesity-and-gestational-diabetes-receive-support-hjelt-diabetes-foundation - 2025-07-07

Published 22 September 2016 People with a hereditary risk of obesity lose as much weight as a result of better diet, exercise and weight loss drugs as the rest of the population, according to an international study presented in The BMJ. “This indicates that even in people at genetic risk of obesity, lifestyle change is an effective way to lose weight”, says Professor Paul Franks of Lund University

https://www.ludc.lu.se/article/no-link-between-obesity-gene-and-intentional-weight-loss - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 19 June 2024 A new method can be used for large-scale screening for type 1 diabetes. The blood test can be done at home. Photograph: Petra Olsson Interest in type 1 diabetes screening is growing as methods improve and new treatments become available to more patients. New research at Lund University demonstrates how screeni

https://www.ludc.lu.se/article/new-method-allows-large-scale-screening-autoimmune-diseases - 2025-07-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 June 2024 The EAT-Lancet diet emphasises a plant-based diet where whole grains, fruits, vegetables, nuts and legumes comprise a greater proportion of foods consumed. Meat and dairy products are consumed in smaller proportions. Photograph: iStock/Magda Tymczyj The EAT-Lancet diet is a framework designed to promote enviro

https://www.ludc.lu.se/article/research-paves-way-sustainable-dietary-recommendations - 2025-07-07